A Novel circ_0075829/miR‐326/GOT1 ceRNA Crosstalk Regulates the Malignant Phenotypes and Drug Sensitivity of Gemcitabine‐Resistant Pancreatic Cancer Cells
Journal of Biochemical and Molecular Toxicology · 2025
DOI: 10.1002/jbt.70089 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Yongjia Xiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Chongqing University Cancer Hospital, Chongqing, China. Hauptthemen laut MEDLINE: Gemcitabine, MicroRNAs, Deoxycytidine, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: This study was granted by Chongqing Shapingba District Science and Technology Bureau Technology Innovation Project (No. 2024158)..
Abstract (Originalsprache)
Although gemcitabine (GEM) is the cornerstone of the treatment of pancreatic cancer (PC), GEM resistance frequently arises. Circular RNA (circRNA) circ_0075829 is highly expressed in PC. However, whether circ_0075829 contributes to GEM resistance of PC is largely unknown. To generate GEM‐resistant PC cells (BxPC‐3/GR and SW1990/GR), we exposed GEM‐sensitive PC cells to GEM. Circ_0075829, microRNA (miR)‐326, and glutamic‐oxaloacetic transaminase 1 (GOT1) were quantified by a qRT‐PCR or western blot method. Cell survival and viability were gauged by MTS assay. Cell proliferation, apoptosis, invasion, and migration were assessed by EdU, flow cytometry, transwell, and wound‐healing assays, respectively. Dual‐luciferase reporter assays were used to verify the relationship between miR‐326 and circ_0075829 or GOT1. Mouse xenografts were performed to evaluate the role of circ_0075829 in vivo. Our data showed that circ_0075829 was upregulated in GEM‐resistant PC tissues and cells. Knockdown of circ_0075829 impeded the proliferation, invasion, migration, and glutamine metabolism, and promoted cell apoptosis and GEM sensitivity of GEM‐resistant PC cells. Moreover, circ_0075829 silencing suppressed the tumorigenicity of SW1990/GR cells and sensitized them to the cytotoxic effect of GME in vivo. Mechanistically, circ_0075829 bound miR‐326 and exerted regulatory effects by affecting miR‐326 expression. GOT1 was a direct miR‐326 target and a key downstream effector of miR‐326. Furthermore, circ_0075829 modulated GOT1 expression via miR‐326. Our findings establish a novel regulatory network, the circ_0075829/miR‐326/GOT1 competing endogenous RNA (ceRNA) crosstalk, in the regulation of GEM resistance in PC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Chongqing University Cancer Hospital, Chongqing, China.
Förderung
- This study was granted by Chongqing Shapingba District Science and Technology Bureau Technology Innovation Project (No. 2024158).
Zitieren
APA
Xiang, Y., Zhou, R., Yang, Y., Bai, H., Liang, F., Wang, H., & Wang, X. (2025). A Novel circ_0075829/miR‐326/GOT1 ceRNA Crosstalk Regulates the Malignant Phenotypes and Drug Sensitivity of Gemcitabine‐Resistant Pancreatic Cancer Cells. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70089
Vancouver
Xiang Y, Zhou R, Yang Y, Bai H, Liang F, Wang H, et al. A Novel circ_0075829/miR‐326/GOT1 ceRNA Crosstalk Regulates the Malignant Phenotypes and Drug Sensitivity of Gemcitabine‐Resistant Pancreatic Cancer Cells. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70089
BibTeX
@article{Xiang2025,
author = {Xiang, Yongjia and Zhou, Rubing and Yang, Yi and Bai, Hao and Liang, Fan and Wang, Hongmei and Wang, Xia},
title = {A Novel circ_0075829/miR‐326/GOT1 ceRNA Crosstalk Regulates the Malignant Phenotypes and Drug Sensitivity of Gemcitabine‐Resistant Pancreatic Cancer Cells},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
doi = {10.1002/jbt.70089}
}
EUVIMED